"pancreatic adenocarcinoma" trang 3 - tải miễn phí từ tailieunhanh
Protocol of the PANCALYZE trial: A multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease

Protocol of the PANCALYZE trial: A multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease
9    53    1
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma

Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
15    76    1
PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma

PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma
12    68    1
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: Correlation of expression, chromosomal status and epigenetic changes

RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: Correlation of expression, chromosomal status and epigenetic changes
9    59    1
Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells

Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells
9    50    1
Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
8    25    1
Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma

Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma
9    40    1
Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: A systematic review

Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: A systematic review
17    22    1
Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma

Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma
18    19    1
A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma

A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma
9    52    1
Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma
16    38    1
Higher body mass index indicated better overall survival in pancreatic ductal adenocarcinoma patients: A real-world study of 2010 patients

Higher body mass index indicated better overall survival in pancreatic ductal adenocarcinoma patients: A real-world study of 2010 patients
11    48    3
Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma

Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma
20    20    1
Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: A retrospective cohort study

Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: A retrospective cohort study
14    30    1
Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: A prospective observational study

Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: A prospective observational study
11    25    1
Molecular signatures of tumor progression in pancreatic adenocarcinoma identified by energy metabolism characteristics

Molecular signatures of tumor progression in pancreatic adenocarcinoma identified by energy metabolism characteristics
16    22    1
The identification of liver metastasisand prognosis-associated genes in pancreatic ductal adenocarcinoma

The identification of liver metastasisand prognosis-associated genes in pancreatic ductal adenocarcinoma
14    9    1
Survival benefit of pembrolizumab for patients with pancreatic adenocarcinoma: A case series

Survival benefit of pembrolizumab for patients with pancreatic adenocarcinoma: A case series
4    1    1
The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma

The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma
15    1    1
CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling

CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling
12    2    1